Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2012
10/10/2012CN102715782A 薰衣草保健被芯 Lavender is a core health
10/10/2012CN102715777A Health quilt core with dafuzhi ginkgo
10/10/2012CN102715776A Health quilt core
10/10/2012CN102715775A Health quilt core
10/10/2012CN102715509A Health care product with function of expelling noxious substances to keep young
10/10/2012CN102327277B Fosinopril sodium and hydrochlorothiazide pharmaceutical composition and preparation method thereof
10/10/2012CN102319252B Amlodipine and fosinopril sodium medical composition and preparation method thereof
10/10/2012CN102302694B Preparation method of traditional Chinese medicine for treating timidity palpitation due to heart deficiency
10/10/2012CN102276683B Smilaxchinoside compound
10/10/2012CN102258622B Traditional Chinese medicine preparation for treating diabetic coronary heart disease and preparation method thereof
10/10/2012CN102258474B Preparation method of self-microemulsifying coenzyme Q10 powdery dry emulsion
10/10/2012CN102228525B Traditional Chinese medicine for treating cardio-cerebral vascular stagnation
10/10/2012CN102225076B Modified Maixuekang preparation, modified Maixuekang enteric-coated preparation as well as preparation methods and applications thereof
10/10/2012CN102210839B Traditional Chinese medicine capsule for treating coronary heart disease
10/10/2012CN102198205B Lianzhi powder and preparation method thereof
10/10/2012CN102178745B Decumbent corydalis tuber vacuum freeze drying process and preparation process for decumbent corydalis tuber powder
10/10/2012CN102161963B Grass root wine and preparation method thereof
10/10/2012CN102127172B Water-soluble coenzyme Q 10 compound and preparation method thereof
10/10/2012CN102085180B Dobutamine hydrochloride injection and preparation method thereof
10/10/2012CN102058592B Azelnidipine and isosorbide dinitrate compound composition
10/10/2012CN102050860B Preparation method of 24(R)-ocotillol DQ and pharmaceutical application thereof
10/10/2012CN102038693B Medicament for inhibiting thrombus formation
10/10/2012CN102018718B Application of Xanthoceraside compound
10/10/2012CN101987847B Novel heterocyclic NF-kB inhibitors
10/10/2012CN101906156B Structures and application of bifunctional protein and derivatives of bifunctional protein
10/10/2012CN101836999B Medicinal composition for curing cardiovascular diseases
10/10/2012CN101768128B Method for refining Valsartan containing more than 10% of isomer
10/10/2012CN101596311B Stable kallikrein-1 injection
10/10/2012CN101472921B Pyridylisoxazole derivative
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101273984B Use of flavone compounds as potassium channel inhibitors
10/10/2012CN101228132B Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors
10/10/2012CN101223184B Glucuronidated nebivolol
10/09/2012US8283377 Method for inhibiting blood vessel stenosis
10/09/2012US8283363 Carboxamide compounds and their use as calpain inhibitors
10/09/2012US8283350 Compositions and methods for reducing capillary permeability
10/09/2012US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof
10/09/2012US8283123 Methods of determination of activation or inactivation of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
10/09/2012CA2633516C Elongase genes and uses thereof
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/09/2012CA2451047C Use of picropodophyllin derivatives for treatment of igf-1r mediated disorders
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/04/2012WO2012135868A2 Compositions and methods for the treatment and prevention of cardiac ischemic injury
10/04/2012WO2012135669A1 Nitrogen ring containing compounds for treatment of inflammatory disorders
10/04/2012WO2012135448A1 Endopeptidase treatment of smooth muscle disorders
10/04/2012WO2012134478A1 Compositions and methods for the treatment and prevention of cardiac ischemic injury
10/04/2012WO2012134332A1 Method for producing a fibrinolytic preparation and use of the latter for treating myocardial infarction
10/04/2012WO2012133945A1 Method for producing cardiomyocyte sheet from embryonic stem cells
10/04/2012WO2012133942A1 Pluripotent stem cell capable of being isolated from fat tissue or umbilical cord of biological body
10/04/2012WO2012133896A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012WO2012133509A1 Novel benzimidazole derivative
10/04/2012WO2012133223A1 Matrix metalloprotease (mmp) production inhibitor for oral use
10/04/2012WO2012133198A1 Nutritional composition for inflammatory diseases
10/04/2012WO2012131633A1 Pyrazolo pyrimidine derivatives
10/04/2012WO2012131379A1 Thieno [2, 3 -d] pyrimidine derivatives and their use to treat arrhythmia
10/04/2012WO2012130829A1 New boranophosphate analogues of cyclic nucleotides
10/04/2012WO2012130821A1 Benzoic acid salt of otamixaban
10/04/2012WO2012130679A1 New azaspirodecanone compounds as hsl inhibitors
10/04/2012WO2012130448A1 A molecular scaffold to modulate thrombin/antithrombin activity by heparin binding
10/04/2012WO2012130166A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
10/04/2012WO2012129792A1 Pyrimidinone compounds, preparation methods, pharmaceutical compositions and uses thereof
10/04/2012WO2012098172A3 N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease
10/04/2012US20120253041 New phenylalanine derivatives
10/04/2012US20120252895 Therapeutic methods employing nitric oxide precursors
10/04/2012US20120252882 Cardiac-specific nucleic acid regulatory elements and methods and use thereof
10/04/2012US20120252875 Methods and compositions for treating diseases, disorders or injury of the cns
10/04/2012US20120252872 RNAi Modulation of APOB and Uses Thereof
10/04/2012US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
10/04/2012US20120252867 Method of therapy and diagnosis of atherosclerosis
10/04/2012US20120252865 Carbamate derivatives in particular for the treatment of neurological disorders
10/04/2012US20120252864 Substituted isoindoline-1,3-dione derivatives
10/04/2012US20120252862 Dissolvable Film Strip Comprising Natural Components
10/04/2012US20120252857 Genotype specific methods for treating human subjects using 4-methylpyrazole
10/04/2012US20120252855 Methods For Treating Degenerative Diseases/Injuries
10/04/2012US20120252852 Otamixaban formulations with improved stability
10/04/2012US20120252850 Niacin conjugated fatty acid mixtures and their uses
10/04/2012US20120252830 Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
10/04/2012US20120252827 Combination of therapy comprising zd6474 and a taxane
10/04/2012US20120252825 Beneficial effects of combination therapy on cholesterol
10/04/2012US20120252824 Drug Combinations and Uses in Treating a Coughing Condition
10/04/2012US20120252823 Adenosine receptor agonists, partial agonists, and antagonists
10/04/2012US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
10/04/2012US20120252815 Inhibitors of sphingosine kinase
10/04/2012US20120252814 Glucokinase Activators
10/04/2012US20120252813 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/04/2012US20120252810 Fatty acid non-flushing niacin derivatives and their uses
10/04/2012US20120252809 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
10/04/2012US20120252805 Novel compounds
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252798 Indole compounds as an inhibitor of cellular necrosis
10/04/2012US20120252795 Oral lysophilisates containing pvp/va
10/04/2012US20120252792 Methods and compositions for modulating rho-mediated gene transcription
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252789 Inhibitors of sphingosine kinase
10/04/2012US20120252788 5ht2c receptor modulators
10/04/2012US20120252782 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
10/04/2012US20120252778 Pyrazolo pyrimidine derivatives
10/04/2012US20120252765 Use of irbesartan for the preparation of a medicament for the prevention of hospitalization for heart failure
10/04/2012US20120252760 Novel pyridopyrazines and their use as modulators of kinases
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 1595